{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T04:33:36Z","timestamp":1776486816405,"version":"3.51.2"},"reference-count":74,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Primary Care: Clinics in Office Practice"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.pop.2021.11.003","type":"journal-article","created":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T07:50:28Z","timestamp":1650613828000},"page":"225-237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Atypical Diabetes and Management Considerations"],"prefix":"10.1016","volume":"49","author":[{"given":"Shivajirao Prakash","family":"Patil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.pop.2021.11.003_bib1","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1111\/j.1464-5491.2011.03409.x","article-title":"Measurement of insulin action: a tribute to Sir Harold Himsworth","volume":"28","author":"Kim","year":"2011","journal-title":"Diabet Med"},{"issue":"2","key":"10.1016\/j.pop.2021.11.003_bib2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2337\/diabetes.50.2.217","article-title":"The discovery of type 1 diabetes","volume":"50","author":"Gale","year":"2001","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.pop.2021.11.003_bib3","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.2337\/diab.28.12.1039","article-title":"Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group","volume":"28","year":"1979","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.pop.2021.11.003_bib4","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.2337\/diacare.20.7.1183","article-title":"Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus","volume":"20","year":"1997","journal-title":"Diabetes Care Jul"},{"issue":"Suppl 1","key":"10.1016\/j.pop.2021.11.003_bib5","first-page":"S15","article-title":"2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2021","volume":"44","year":"2021","journal-title":"Diabetes Care"},{"issue":"12 Suppl","key":"10.1016\/j.pop.2021.11.003_bib6","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.4065\/mcp.2010.0466","article-title":"The increasing role of primary care physicians in caring for patients with type 2 diabetes mellitus","volume":"85","author":"Davidson","year":"2010","journal-title":"Mayo Clin Proc"},{"issue":"Suppl 2","key":"10.1016\/j.pop.2021.11.003_bib7","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/dmrr.2345","article-title":"Latent autoimmune diabetes in the adults (LADA) in Asia: from pathogenesis and epidemiology to therapy","volume":"28","author":"Guglielmi","year":"2012","journal-title":"Diabetes Metab Res Rev"},{"issue":"12","key":"10.1016\/j.pop.2021.11.003_bib8","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1210\/jc.2009-1120","article-title":"Latent autoimmune diabetes in adults","volume":"94","author":"Naik","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.pop.2021.11.003_bib9","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.2337\/dbi20-0017","article-title":"Management of latent autoimmune diabetes in adults: a consensus statement from an international expert panel","volume":"69","author":"Buzzetti","year":"2020","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.pop.2021.11.003_bib10","doi-asserted-by":"crossref","first-page":"260","DOI":"10.4093\/dmj.2019.0007","article-title":"Glutamic acid decarboxylase autoantibody detection by electrochemiluminescence assay identifies latent autoimmune diabetes in adults with poor islet function","volume":"44","author":"Zhu","year":"2020","journal-title":"Diabetes Metab J"},{"issue":"7","key":"10.1016\/j.pop.2021.11.003_bib11","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s00125-019-4863-8","article-title":"Type 1 diabetes defined by severe insulin deficiency occurs after 30 years of age and is commonly treated as type 2 diabetes","volume":"62","author":"Thomas","year":"2019","journal-title":"Diabetologia"},{"issue":"9","key":"10.1016\/j.pop.2021.11.003_bib12","doi-asserted-by":"crossref","first-page":"e031586","DOI":"10.1136\/bmjopen-2019-031586","article-title":"Development and validation of multivariable clinical diagnostic models to identify type 1 diabetes requiring rapid insulin therapy in adults aged 18-50 years","volume":"9","author":"Lynam","year":"2019","journal-title":"BMJ Open"},{"issue":"Suppl 2","key":"10.1016\/j.pop.2021.11.003_bib13","doi-asserted-by":"crossref","first-page":"S246","DOI":"10.2337\/dc09-S317","article-title":"Beta-cell protection and therapy for latent autoimmune diabetes in adults","volume":"32","author":"Cernea","year":"2009","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.pop.2021.11.003_bib14","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.2337\/diabetes.53.12.3193","article-title":"ADOPT Study Group. Phenotypic characteristics of GAD antibody-positive recently diagnosed patients with type 2 diabetes in North America and Europe","volume":"53","author":"Zinman","year":"2004","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.pop.2021.11.003_bib15","doi-asserted-by":"crossref","first-page":"908","DOI":"10.2337\/dc12-0931","article-title":"Action LADA consortium. Adult-onset autoimmune diabetes in Europe is prevalent with a broad clinical phenotype: Action LADA 7","volume":"36","author":"Hawa","year":"2013","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.pop.2021.11.003_bib16","doi-asserted-by":"crossref","first-page":"543","DOI":"10.2337\/db12-0207","article-title":"LADA China Study Group. Frequency, immunogenetics, and clinical characteristics of latent autoimmune diabetes in China (LADA China study): a nationwide, multicenter, clinic-based cross-sectional study","volume":"62","author":"Zhou","year":"2013","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.pop.2021.11.003_bib17","doi-asserted-by":"crossref","first-page":"451","DOI":"10.4093\/dmj.2018.0190","article-title":"Latent autoimmune diabetes in adults: a review on clinical implications and management","volume":"42","author":"Pieralice","year":"2018","journal-title":"Diabetes Metab J"},{"issue":"1","key":"10.1016\/j.pop.2021.11.003_bib18","doi-asserted-by":"crossref","first-page":"66","DOI":"10.2337\/dc10-0488","article-title":"Prevalence and correlates of latent autoimmune diabetes in adults in Tianjin, China: a population-based cross-sectional study","volume":"34","author":"Qi","year":"2011","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.pop.2021.11.003_bib19","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/dmrr.1278","article-title":"KNDP Collaboratory Group. LADA prevalence estimation and insulin dependency during follow-up","volume":"27","author":"Park","year":"2011","journal-title":"Diabetes Metab Res Rev"},{"issue":"2","key":"10.1016\/j.pop.2021.11.003_bib20","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00592-010-0228-y","article-title":"The prevalence and characteristics of latent autoimmune diabetes in adults (LADA) and its relation with chronic complications in a clinical department of a university hospital in Korea","volume":"50","author":"Roh","year":"2013","journal-title":"Acta Diabetol"},{"issue":"12","key":"10.1016\/j.pop.2021.11.003_bib21","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.2337\/dc07-0896","article-title":"Latent autoimmune diabetes in adults in a South Asian population of the U.K","volume":"30","author":"Britten","year":"2007","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.pop.2021.11.003_bib22","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/dme.12644","article-title":"Low prevalence of latent autoimmune diabetes in adults in northern India","volume":"32","author":"Sachan","year":"2015","journal-title":"Diabet Med"},{"issue":"8","key":"10.1016\/j.pop.2021.11.003_bib23","doi-asserted-by":"crossref","first-page":"e0131837","DOI":"10.1371\/journal.pone.0131837","article-title":"Latent autoimmune diabetes in adults in the United Arab Emirates: clinical features and factors related to insulin-requirement","volume":"10","author":"Maddaloni","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.pop.2021.11.003_bib24","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1399-0039.2006.00745.x","article-title":"Insulin gene VNTR, CTLA-4\u00a0+49A\/G and HLA-DQB1 alleles distinguish latent autoimmune diabetes in adults from type 1 diabetes and from type 2 diabetes group","volume":"69","author":"Haller","year":"2007","journal-title":"Tissue Antigens"},{"issue":"11","key":"10.1016\/j.pop.2021.11.003_bib25","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrendo.2017.99","article-title":"Adult-onset autoimmune diabetes: current knowledge and implications for management","volume":"13","author":"Buzzetti","year":"2017","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"10.1016\/j.pop.2021.11.003_bib26","doi-asserted-by":"crossref","first-page":"970","DOI":"10.2337\/dc05-2101","article-title":"A\u00a0clinical screening tool identifies autoimmune diabetes in adults","volume":"29","author":"Fourlanos","year":"2006","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.pop.2021.11.003_bib27","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1530\/EJE-10-0901","article-title":"\u03b2-cell function and metabolic control in latent autoimmune diabetes in adults with early insulin versus conventional treatment: a 3-year follow-up","volume":"164","author":"Thunander","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.pop.2021.11.003_bib28","doi-asserted-by":"crossref","first-page":"622","DOI":"10.2337\/diab.45.5.622","article-title":"Small doses of subcutaneous insulin as a strategy for preventing slowly progressive beta-cell failure in islet cell antibody-positive patients with clinical features of NIDDM","volume":"45","author":"Kobayashi","year":"1996","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.pop.2021.11.003_bib29","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1210\/jc.2007-2267","article-title":"Insulin intervention in slowly progressive insulin-dependent (type 1) diabetes mellitus","volume":"93","author":"Maruyama","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.pop.2021.11.003_bib30","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1210\/jc.2019-00129","article-title":"Metformin improves peripheral insulin sensitivity in youth with type 1 diabetes","volume":"104","author":"Cree-Green","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.pop.2021.11.003_bib31","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1007\/s00125-017-4364-6","article-title":"A\u00a0new perspective on metformin therapy in type 1 diabetes","volume":"60","author":"Livingstone","year":"2017","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.pop.2021.11.003_bib32","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/dmrr.503","article-title":"Rosiglitazone combined with insulin preserves islet beta cell function in adult-onset latent autoimmune diabetes (LADA)","volume":"21","author":"Zhou","year":"2005","journal-title":"Diabetes Metab Res Rev"},{"issue":"1","key":"10.1016\/j.pop.2021.11.003_bib33","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.diabres.2008.09.044","article-title":"Rosiglitazone preserves islet beta-cell function of adult-onset latent autoimmune diabetes in 3 years follow-up study","volume":"83","author":"Yang","year":"2009","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"10.1016\/j.pop.2021.11.003_bib34","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.2337\/dc13-1523","article-title":"C-peptide levels in latent autoimmune diabetes in adults treated with linagliptin versus glimepiride: exploratory results from a 2-year double-blind, randomized, controlled study","volume":"37","author":"Johansen","year":"2014","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.pop.2021.11.003_bib35","doi-asserted-by":"crossref","first-page":"E876","DOI":"10.1210\/jc.2013-3633","article-title":"Dipeptidyl peptidase 4 inhibitor sitagliptin maintains \u03b2-cell function in patients with recent-onset latent autoimmune diabetes in adults: one year prospective study","volume":"99","author":"Zhao","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.pop.2021.11.003_bib36","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s13300-017-0299-7","article-title":"Possible long-term efficacy of sitagliptin, a dipeptidyl peptidase-4 inhibitor, for slowly progressive type 1 diabetes (SPIDDM) in the stage of non-insulin-dependency: an open-label randomized controlled pilot trial (SPAN-S)","volume":"8","author":"Awata","year":"2017","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.pop.2021.11.003_bib37","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1111\/dom.13237","article-title":"Dulaglutide treatment results in effective glycaemic control in latent autoimmune diabetes in adults (LADA): a post-hoc analysis of the AWARD-2, -4 and -5 Trials","volume":"20","author":"Pozzilli","year":"2018","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"10.1016\/j.pop.2021.11.003_bib38","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.18549\/PharmPract.2019.4.1588","article-title":"Combination therapy with once-weekly glucagon like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes: a case series","volume":"17","author":"Lajthia","year":"2019","journal-title":"Pharm Pract (Granada)"},{"issue":"6","key":"10.1016\/j.pop.2021.11.003_bib39","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.2337\/dc18-2316","article-title":"International consensus on risk management of diabetic ketoacidosis in patients with type 1 diabetes treated with sodium-glucose cotransporter (SGLT) inhibitors","volume":"42","author":"Danne","year":"2019","journal-title":"Diabetes Care"},{"issue":"Suppl. 1","key":"10.1016\/j.pop.2021.11.003_bib40","first-page":"S111","article-title":"9. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes - 2021","volume":"44","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pop.2021.11.003_bib41","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s00125-009-1371-2","article-title":"GAD65 vaccination: 5 years of follow-up in a randomized dose-escalating study in adult-onset autoimmune diabetes","author":"Agardh","year":"2009","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.pop.2021.11.003_bib42","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.metabol.2015.12.007","article-title":"The evolution of diabetic ketoacidosis: an update of its etiology, pathogenesis and management","volume":"65","author":"Nyenwe","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.pop.2021.11.003_bib43","doi-asserted-by":"crossref","first-page":"362","DOI":"10.15585\/mmwr.mm6712a3","article-title":"Trends in diabetic ketoacidosis hospitalizations and in-hospital mortality \u2014 United States, 2000\u20132014","volume":"67","author":"Benoit","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"10.1016\/j.pop.2021.11.003_bib44","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/17446651.2019.1561270","article-title":"Evaluation and management of ketosis-prone diabetes","volume":"14","author":"Gaba","year":"2019","journal-title":"Expert Rev Endocrinol Metab"},{"issue":"5554","key":"10.1016\/j.pop.2021.11.003_bib45","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/bmj.2.5554.747","article-title":"Diabetes in the tropics","volume":"2","author":"Dodu","year":"1967","journal-title":"Br Med J"},{"issue":"4","key":"10.1016\/j.pop.2021.11.003_bib46","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/0035-9203(68)90138-7","article-title":"\u201cTemporary diabetes\u201d in adult Nigerians","volume":"62","author":"Adadevoh","year":"1968","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"6","key":"10.1016\/j.pop.2021.11.003_bib47","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1056\/NEJM198702053160601","article-title":"Maturity-onset diabetes of youth in black Americans","volume":"316","author":"Winter","year":"1987","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.pop.2021.11.003_bib48","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2337\/diab.43.6.741","article-title":"GAD antibody negative NIDDM in adult black subjects with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 and DR4. Flatbush diabetes","volume":"43","author":"Banerji","year":"1994","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.pop.2021.11.003_bib49","doi-asserted-by":"crossref","first-page":"790","DOI":"10.2337\/diab.44.7.790","article-title":"Diabetic ketoacidosis in obese African-Americans","volume":"44","author":"Umpierrez","year":"1995","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.pop.2021.11.003_bib50","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.2337\/diacare.22.9.1517","article-title":"Immunogenetic analysis suggests different pathogenesis for obese and lean African-Americans with diabetic ketoacidosis","volume":"22","author":"Umpierrez","year":"1999","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.pop.2021.11.003_bib51","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/00000441-199511000-00004","article-title":"Ketoacidosis-onset noninsulin dependent diabetes in Japanese subjects","volume":"310","author":"Aizawa","year":"1995","journal-title":"Am J Med Sci"},{"issue":"18","key":"10.1016\/j.pop.2021.11.003_bib52","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1001\/archinte.1997.00440390094012","article-title":"Ketoacidosis in Apache Indians with non-insulin-dependent diabetes mellitus","volume":"157","author":"Wilson","year":"1997","journal-title":"Arch Intern Med"},{"issue":"19","key":"10.1016\/j.pop.2021.11.003_bib53","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1001\/archinte.159.19.2317","article-title":"New profiles of diabetic ketoacidosis: type 1 vs type 2 diabetes and the effect of ethnicity","volume":"159","author":"Balasubramanyam","year":"1999","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.pop.2021.11.003_bib54","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0002-9343(96)00076-9","article-title":"The occurrence of diabetic ketoacidosis in non-insulin-dependent diabetes and newly diagnosed diabetic adults","volume":"101","author":"Westphal","year":"1996","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.pop.2021.11.003_bib55","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.2337\/diacare.24.6.1014","article-title":"Idiopathic type 1 diabetes in Dallas, Texas: a 5-year experience","volume":"24","author":"Pinero-Pilona","year":"2001","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.pop.2021.11.003_bib56","doi-asserted-by":"crossref","first-page":"442","DOI":"10.4158\/EP.14.4.442","article-title":"Diabetic ketoacidosis in Peruvian patients with type 2 diabetes mellitus","volume":"14","author":"Pinto","year":"2008","journal-title":"Endocr Pract"},{"issue":"16","key":"10.1016\/j.pop.2021.11.003_bib57","first-page":"576","article-title":"Characteristics of Caucasian type 2 diabetic patients during ketoacidosis and at follow-up","volume":"130","author":"Pitteloud","year":"2000","journal-title":"Schweiz Med Wochenschr"},{"issue":"8","key":"10.1016\/j.pop.2021.11.003_bib58","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/j.1464-5491.2004.01249.x","article-title":"Clinical characteristics and outcomes of diabetic ketoacidosis in Pakistani adults with type 2 diabetes mellitus","volume":"21","author":"Jabbar","year":"2004","journal-title":"Diabet Med"},{"issue":"9","key":"10.1016\/j.pop.2021.11.003_bib59","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.jdiacomp.2017.06.008","article-title":"Clinical characteristics, beta-cell dysfunction and treatment outcomes in patients with A\u2212\u03b2+ ketosis-prone diabetes (KPD): the first identified cohort amongst Asian Indians","volume":"31","author":"Gupta","year":"2017","journal-title":"J\u00a0Diabet Complications"},{"issue":"3","key":"10.1016\/j.pop.2021.11.003_bib60","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2337\/diacare.23.3.335","article-title":"Metabolic and immunologic features of Chinese patients with atypical diabetes mellitus","volume":"23","author":"Tan","year":"2000","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.pop.2021.11.003_bib61","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1016\/j.diabres.2009.04.017","article-title":"Clinical characteristics of Korean patients with new-onset diabetes presenting with diabetic ketoacidosis","volume":"85","author":"Kim","year":"2009","journal-title":"Diabetes Res Clin Pract"},{"issue":"5","key":"10.1016\/j.pop.2021.11.003_bib62","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/dme.12638","article-title":"Changes in circulating adiponectin, leptin, glucose and C-peptide in patients with ketosis-prone diabetes","volume":"32","author":"Gupta","year":"2015","journal-title":"Diabet Med"},{"issue":"11","key":"10.1016\/j.pop.2021.11.003_bib63","doi-asserted-by":"crossref","first-page":"5087","DOI":"10.1210\/jc.2003-031656","article-title":"Ketosis-prone diabetes--a new subgroup of patients with atypical type 1 and type 2 diabetes?","volume":"88","author":"Kitabchi","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.pop.2021.11.003_bib64","doi-asserted-by":"crossref","first-page":"971","DOI":"10.4158\/EP161679.RA","article-title":"Diabetic ketoacidosis: a common debut of diabetes among African Americans with type 2 diabetes","volume":"23","author":"Vellanki","year":"2017","journal-title":"Endocr Pract"},{"issue":"6","key":"10.1016\/j.pop.2021.11.003_bib65","doi-asserted-by":"crossref","first-page":"589","DOI":"10.2217\/dmt.11.57","article-title":"Update on diagnosis, pathogenesis and management of ketosis-prone type 2 diabetes mellitus","volume":"1","author":"Smiley","year":"2011","journal-title":"Diabetes Manag (Lond)"},{"issue":"6","key":"10.1016\/j.pop.2021.11.003_bib66","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S1056-8727(01)00172-6","article-title":"Idiopathic type 1 diabetes","volume":"15","author":"Pinero-Pilona","year":"2001","journal-title":"J\u00a0Diabetes Complications"},{"issue":"3","key":"10.1016\/j.pop.2021.11.003_bib67","doi-asserted-by":"crossref","first-page":"645","DOI":"10.2337\/diabetes.53.3.645","article-title":"Ketosis-prone type 2 diabetes in patients of sub-Saharan African origin: clinical pathophysiology and natural history of beta-cell dysfunction and insulin resistance","volume":"53","author":"Mauvais-Jarvis","year":"2004","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.pop.2021.11.003_bib68","doi-asserted-by":"crossref","first-page":"5090","DOI":"10.1210\/jc.2003-030180","article-title":"Ketosis-prone diabetes: dissection of a heterogeneous syndrome using an immunogenetic and beta-cell functional classification, prospective analysis, and clinical outcomes","volume":"88","author":"Maldonado","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.pop.2021.11.003_bib69","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.2337\/dc06-0749","article-title":"Accuracy and predictive value of classification schemes for ketosis-prone diabetes","volume":"29","author":"Balasubramanyam","year":"2006","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.pop.2021.11.003_bib70","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.2337\/dc16-0406","article-title":"Randomized controlled study of metformin and sitagliptin on long-term normoglycemia remission in African American patients with hyperglycemic crises","volume":"39","author":"Vellanki","year":"2016","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.pop.2021.11.003_bib71","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1046\/j.1464-5491.2001.00395.x","article-title":"Near-normoglycaemic remission in African-Americans with type 2 diabetes mellitus is associated with recovery of beta cell function","volume":"18","author":"McFarlane","year":"2001","journal-title":"Diabet Med"},{"issue":"12","key":"10.1016\/j.pop.2021.11.003_bib72","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.2337\/dc14-0893","article-title":"Liraglutide and the preservation of pancreatic \u03b2-cell function in early type 2 diabetes: the LIBRA trial","volume":"37","author":"Retnakaran","year":"2014","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.pop.2021.11.003_bib73","doi-asserted-by":"crossref","first-page":"479","DOI":"10.2337\/diacare.20.4.479","article-title":"Sulfonylurea treatment prevents recurrence of hyperglycemia in obese African-American patients with a history of hyperglycemic crises","volume":"20","author":"Umpierrez","year":"1997","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.pop.2021.11.003_bib74","doi-asserted-by":"crossref","first-page":"466","DOI":"10.2337\/diab.44.4.466","article-title":"Prolongation of near-normoglycemic remission in black NIDDM subjects with chronic low-dose sulfonylurea treatment","volume":"44","author":"Banerji","year":"1995","journal-title":"Diabetes"}],"container-title":["Primary Care: Clinics in Office Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009545432101633X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009545432101633X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T15:53:20Z","timestamp":1758815600000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009545432101633X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":74,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S009545432101633X"],"URL":"https:\/\/doi.org\/10.1016\/j.pop.2021.11.003","relation":{},"ISSN":["0095-4543"],"issn-type":[{"value":"0095-4543","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atypical Diabetes and Management Considerations","name":"articletitle","label":"Article Title"},{"value":"Primary Care: Clinics in Office Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pop.2021.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}